Etiometry Does a Double Take – Expands Client Base Twofold in One Year
News and Press Releases
BOSTON, December 18, 2018 – From Omaha to Pakistan, Etiometry has doubled their client base in the last year. These new partnerships are placing the Etiometry Platform beside hundreds of beds, and empowering clinicians to make data-driven decisions on more than tens of thousands of patients per year. “Every partnership is a chance to improve countless outcomes for patients at the most critical point in their care. We are honored to work with the top academic medical centers in the world and we strive to make our software the industry standard,” explained Etiometry’s COO Evan Butler.
As the company continues to gain momentum as the industry leader in dynamic analytics for critical care, they’ve got a new focus for partners in 2019. Since earning FDA clearance on their first Risk Analytics Algorithm for neonates in 2016, the company has been committed to expanding this potentially life-saving software to a larger audience. According to Etiometry CTO Dr. Dimitar Baronov, “Rather than creating isolated algorithms to estimate adverse patient outcomes, Etiometry’s innovative technology allows the company to comprehensively and continuously track physiologic risks, which enables the care teams to avoid patient harm.” Etiometry’s T3 Software is cleared for patients of any age; however, the company’s current FDA clearance for the IDO2 Index allows use on patients ages 12 and under. Etiometry is in the process of obtaining FDA clearance for adult patients and is currently accepting research partnerships with academic medical centers specializing in adult medicine.
About Etiometry
Etiometry Inc. is the leader in clinical decision-support software for the intensive care environment. Our technologies provide valuable clinical insight and analysis to support early recognition of subtle changes in patient condition to avoid complications and speed recovery. Etiometry is committed to improving patient outcomes, increasing clinical efficiency, and lowering costs of care through the more effective use of all available data.
For more information, visit www.etiometry.com.
We’d love to hear from you
Whether you’re curious about how Etiometry can help support your team, the platform’s latest outcomes data or a demo – we’re ready to answer your questions.
Contact UsRelated
Boston Children’s Hospital Multi-center Study Finds Etiometry’s Risk Analytics Algorithms May Help Assess Extubation Failure Following Congenital Cardiac Surgery
Results published in Pediatric Critical Care Medicine demonstrate that the IDO2 and IVCO2 Indices may support more informed ventilator liberation decisions May 19, 2025 – BOSTON – A newly published multi-center study has found that Etiometry’s FDA-cleared physiologic risk analytics—IDO2 and IVCO2—were found to be associated with increased risk of extubation failure in retrospective analysis, […]
Health Tech: Shane Cooke Of Etiometry On How Their Technology Can Make An Important Impact On Our Overall Wellness
An Interview With David Leichner published by Authority Magazine From discussing the five things every health tech founder should know, to the real-world impact of Etiometry’s technology in the ICU, this piece offers a compelling look into the mission driving our team forward every day. Read the full interview HERE
Recent Data Highlights the Critical Role of the Etiometry Platform in Assessing Compliance and Opportunities for Improvement in Neonatal Oxygen Therapy
Abstract presented at the 2025 Pediatric Academic Societies (PAS) Annual Meeting April 28, 2025 – BOSTON – A recent study conducted at Children’s National Hospital in Washington, D.C., examined the role of Etiometry’s near real-time clinical intelligence platform in assessing neonatal oxygen therapy compliance and identifying potential areas for improvement. The findings were presented this […]